Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 43 - Drugs for specific purposes, not provided for in groups
Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317)
06/1998
06/10/1998EP0846687A1 Pyrazoles as human non-pancreatic secretory phospholipase A2 inhibitors
06/10/1998EP0846685A1 3-Hydroxypyridine-2-carboxylic acid amide esters, their preparation and their use as medicaments
06/10/1998EP0846464A2 Use of glycogen phosphorylase inhibitor for reducing non-cardiac tissue damage resulting from ischemia
06/10/1998EP0846116A1 1-benzoyl-2-(indolyl-3-alkyl)-piperazine derivatives as neurokinin receptor antagonists
06/10/1998EP0846110A1 Thf-containing sulfonamide inhibitors of aspartyl protease
06/10/1998EP0846108A1 Amino-substituted thiadiazoles, pyrimidines, triazines or triazoles useful as ctf receptor antagonists
06/10/1998EP0845993A1 Use of plasminogene activators to stimulate local bone growth
06/10/1998EP0845987A1 C-proteinase inhibitors for the treatment of disorders related to the overproduction of collagen
06/10/1998EP0845939A2 Lysosomal proteins produced in the milk of transgenic animals
06/10/1998EP0693054B1 Cycloalkylhydroxyureas and their use as lipoxygenase inhibitors
06/10/1998EP0675719B1 Novel combination of benzoquinazoline antifolates and protecting agents
06/10/1998EP0487627B1 Wound healing preparations containing heparanase
06/10/1998DE19650975A1 Neue heterocyclisch substituierte Benzamide und deren Anwendung New heterocyclic-substituted benzamides and their application
06/10/1998DE19650778A1 Dopamine receptor antagonists
06/10/1998CN1184475A Tetralin compounds with MDR activity
06/10/1998CN1184474A Oxygenated-heterocycle containing sulfonamide inhibitors of aspartyl protease
06/10/1998CN1184472A Reversible protease inhibitors
06/10/1998CN1184470A Thienyl-, Furyl-, Pyrrolyl- and biphenylsulfonamides and derivatives thereof that modulate the activity of endothelin
06/10/1998CN1184469A 1 -phenylpyrazole-3 -carboxamides acting on neurotensin receptors
06/10/1998CN1184431A Therapeutic composition comprising an antigen or an in vivo generator for generating a compound comprising an amino acid sequence
06/10/1998CN1184430A Compositions of interleukin and pyrimidine nucleosides
06/10/1998CN1184427A 抗真菌组合物 Antifungal compositions
06/10/1998CN1184425A 5 -substituted -3 -(1, 2, 3, 6 -tetrahydro -pyridin -4 -yl) - and 3 -(piperidin -4 -yl) -1h -indoles: new 5 -HT1f agonists
06/10/1998CN1184424A New pharmacological use of all-receptor antagonists
06/10/1998CN1184404A Improved method for controlling ectoparasites
06/10/1998CN1184105A Substituted thiazolidine derivatives and pharmaceutical compositions containing them and use thereof
06/10/1998CN1184104A 3 -hydroxy -pyridine -2 -carboxylic amide ester, and its preparation and its application as medicine
06/10/1998CN1038680C Dihydronaphtho £1, 2-b| pyrane derivative and its producing process and use
06/09/1998US5763673 Diarylheptanoide derivative and pharmaceutical composition comprising the same
06/09/1998US5763621 Reaction of acid compound with hydroxylamine compound or amidation of acid
06/09/1998US5763611 Treating osteoporosis, rheumatoid arthritis
06/09/1998US5763569 Polypeptides as calcium receptors to generate antibodies
06/09/1998US5763567 Human amino acid sequences which can bind to and/or neutralize heparin
06/09/1998US5763504 Photcurable glycosaminoglycan derivatives, crosslinked glycosaminoglycans and method of production thereof
06/09/1998US5763496 Selected from catechols and ortho-methoxyphenols
06/09/1998US5763489 Naphthalene derivatives as prostaglandin I2 agonsists
06/09/1998US5763487 Skin disorders, cardiovascular disorders and cosmetics
06/09/1998US5763470 Benzopyran compounds and methods for their use
06/09/1998US5763460 N-(piperidinyl-1-alkyl)-substituted cyclohexane carboxylic acid amides as 5-htia receptor antagonists
06/09/1998US5763458 1-phenylalkanone 5-HT4 receptor ligands
06/09/1998US5763433 Pharmaceutical compositions containing 3-beta-hydroxylated 6,7-substituted steroid derivatives, and use thereof
06/09/1998US5763414 Administering to mammal to treat hypercholesterolemia
06/09/1998US5763399 Revitalizing tissues with growth factor
06/09/1998US5763276 Processes for the purification of human recombinant decorin and the detection of guandinium ions
06/09/1998US5763246 DNA encoding arginyl tRNA synthetase from staphylococcus aureus
06/09/1998US5763220 Human apoptosis-related calcium-binding protein
06/09/1998US5763214 Fibroblast growth factor 11
06/09/1998US5763210 Recombinant production of interferon-gamma binding proteins
06/09/1998US5763164 Immunogenic cancer proteins and peptides and methods of use
06/09/1998US5762922 Antioxidants and intracellular gluthathione raising agents for therapeutic treatments
06/09/1998CA2157142C Treatment of diseases caused by sebaceous gland disorders
06/09/1998CA2120133C Crystalline amifostine compositions and methods for the preparation and use of same
06/09/1998CA2027483C Process for the preparation of an aqueous effervescent solution with emollient action on nail cuticle, composition for said process and corresponding cosmetic treatment
06/05/1998CA2223317A1 Method of reducing tissue damage associated with non-cardiac ischemia using glycogen phosphorylase inhibitors
06/04/1998WO1998023760A1 Phosphatidylinositol 3-kinase p110 delta catalytic subunit
06/04/1998WO1998023745A1 Human sqm1 protein homolog comprising a cell adhesion protein
06/04/1998WO1998023648A1 New butyric esters with antiproliferative activity and the pharmaceutical compositions containing them
06/04/1998WO1998023625A1 Synthetic glycoamines, methods for their use that affect cell
06/04/1998WO1998023617A1 Hetero-biaryl-pyridoquinazolinone derivatives as anti-cancer agents
06/04/1998WO1998023616A1 Biaryl-pyridoquinazolinone derivatives as anti-cancer agents
06/04/1998WO1998023613A1 Fused bicyclic pyrimidine derivatives
06/04/1998WO1998023611A1 2-imidazolinylaminobenzoxazole compounds useful as alpha-2 adrenoceptor agonists
06/04/1998WO1998023609A1 2-imidazolinylaminoindazole compounds useful as alpha-2 adrenoceptor agonists
06/04/1998WO1998023608A1 Novel integrin receptor antagonists
06/04/1998WO1998023607A1 1,4-dihydropyridine derivatives
06/04/1998WO1998023603A1 Dimesylate salts of neuropeptide y ligands
06/04/1998WO1998023593A1 Apo b-secretion/mtp inhibitory amides
06/04/1998WO1998023591A1 Guanidinylamino heterocycle compounds useful as alpha-2 adrenoceptor agonists
06/04/1998WO1998023588A1 Metalloproteinase inhibitors
06/04/1998WO1998023587A1 5-cyclo indole compounds as 5-ht1d receptor ligands
06/04/1998WO1998023581A1 Benzamidoaldehydes and their use as cysteine protease inhibitors
06/04/1998WO1998023299A2 Radiolabeled dna oligonucleotide, method of preparation and therapeutic uses thereof
06/04/1998WO1998023284A1 Method of regulating nitric oxide production
06/04/1998WO1998023277A1 Use of mixtures of active substances, containing phytostenols and/or phytostenol esters and potentiators, for the production of hypocholesteremic agents
06/04/1998WO1998023275A1 Use of mixtures of active substances for the production of hypocholesteremic agents
06/04/1998WO1998023273A1 4-aryl-3-hydroxyquinolin-2-one derivatives as ion channel modulators
06/04/1998WO1998023267A1 Use of hydroxyguanidines
06/04/1998WO1998023243A2 Pharmaceutical, cosmetic composition with base of microbial culture mixed with an essential oil and an acid
06/04/1998WO1998017325A3 Covalent polar lipid conjugates for targeting
06/04/1998WO1998013493A3 A family of genes encoding apoptosis-related peptides, peptides encoded thereby and methods of use thereof
06/04/1998CA2273512A1 Pharmaceutical, cosmetic composition with base of microbial culture mixed with an essential oil and an acid
06/04/1998CA2273341A1 Use of mixtures of active substances, containing phytostenols and/or phytostenol esters and potentiators, for the production of hypocholesterolemic preparations
06/04/1998CA2272992A1 Synthetic glycoamines, methods for their use that affect cell
06/04/1998CA2272945A1 1,4-dihydropyridine derivatives
06/04/1998CA2272932A1 Use of hydroxyguanidines
06/04/1998CA2272916A1 Biaryl-pyridoquinazolinone derivatives as anti-cancer agents
06/04/1998CA2272915A1 Hetero-biaryl-pyridoquinazolinone derivatives as anti-cancer agents
06/04/1998CA2272754A1 Use of mixtures of active substances for the production of hypocholesterolemic agents
06/04/1998CA2272683A1 2-imidazolinylaminobenzoxazole compounds useful as alpha-2 adrenoceptor agonists
06/04/1998CA2272644A1 2-imidazolinylaminoindazole compounds useful as alpha-2 adrenoceptor agonists
06/04/1998CA2272565A1 Integrin receptor antagonists
06/04/1998CA2272388A1 Benzamidoaldehydes and their use as cysteine protease inhibitors
06/04/1998CA2271689A1 Radiolabeled dna oligonucleotide, method of preparation and therapeutic uses thereof
06/04/1998CA2270283A1 Human sqm1 protein homolog comprising a cell adhesion protein
06/04/1998CA2266605A1 4-aryl-3-hydroxyquinolin-2-one derivatives as ion channel modulators
06/04/1998CA2243944A1 Phosphatidylinositol 3-kinase p110 delta catalytic subunit
06/04/1998CA2223541A1 New imidazoline derivatives, preparation process and the pharmaceutical compositions containing them
06/04/1998CA2223366A1 3-hydroxypyridine-2-carboxamidoesters, their preparation and their use as pharmaceuticals
06/03/1998EP0845539A1 Isolation and purification of tetrahydropyrimidine derivatives
06/03/1998EP0845535A2 Leader peptidase (lep) from Streptococcus
1 ... 1286 1287 1288 1289 1290 1291 1292 1293 1294 1295 1296 1297 1298 1299 1300 1301 1302 1303 1304 1305 1306 ... 1564